Alpha Tau Medical Ltd. Warrant (DRTSW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Alpha Tau Medical Ltd. Warrant (DRTSW) is up 429.4% since the beginning of the year. At $2 per share, DRTSW is trading 39.8% below its 52-week high of $3. Investors who bought $1,000 worth of DRTSW shares 5 years ago would now be looking at an investment worth $2,647.

Alpha Tau Medical Ltd. Warrant (DRTSW) has returned 429.38% so far this year and 662.67% over the past 12 months.

Based on dividend-adjusted daily data since Mar 8, 2021, DRTSW's average daily return is +0.47%, while the average monthly return is +5.84%. At this rate, an investment would double in approximately 1.0 years.

Historically, 44% of months were positive and 56% were negative. The best month was Jan 2026 with a return of +166.5%, while the worst month was Mar 2021 at -37.0%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.

On a daily basis, DRTSW closed higher 37% of trading days. The best single day was Aug 6, 2024 with a return of +79.3%, while the worst single day was Jan 8, 2025 at -50.9%.

Alpha Tau Medical Ltd. Warrant has an annualized alpha of 193.51%, beta of 0.68, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 08, 2021.

• This stock captured 337.14% of S&P 500 Index gains and 217.50% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• Beta of 0.68 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

DRTSW ranks 97 for risk / return — in the top 97% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Alpha Tau Medical Ltd. Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alpha Tau Medical Ltd. Warrant was 89.40%, occurring on Aug 5, 2024. Recovery took 362 trading sessions.

The current Alpha Tau Medical Ltd. Warrant drawdown is 38.99%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Alpha Tau Medical Ltd. Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Alpha Tau Medical Ltd. Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.